A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy

BACKGROUND: Because of rapid disease progression and lack of optimal treatment strategies beyond the second‐line, the prognosis of patients with extensive‐stage (ES) small cell lung cancer (SCLC) still remains depressing. Alternative treatment strategies are required to improve their prognosis. In t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Liu, Yutao, Hu, Xingsheng, Jiang, Jun, Yang, Lin, Zhou, Shengyu, Liu, Peng, Li, Junling, Wang, Yan, Hao, Xuezhi, Shi, Yuankai
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Lung Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216448/
https://ncbi.nlm.nih.gov/pubmed/32250517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0391
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars